Exclusive workshop on extending the half-life of Peptides added to SMi Group inaugural event

LONDON - April 24, 2014 - PRLog -- Workshop leader Yvonne Angell, Director of Peptide and Protein Chemistry, Ipsen Inc. will be covering:

Can the chemical modification technologies be able to compete with sustained-release (SR) formulations?
What would be the key advantages of peptide conjugation vs SR formulations for half-life extension?
Are there specific situations where conjugation brings something that SR formulation cannot achieve?

The two-day conference focusing on optimisation, extending the half-life and assessing alternative technologies in peptide analysis will feature 15 leading speakers to include:

·         Thomas Vorherr, Director Peptide Discovery, Novartis Pharma AG

·         David Price, Senior Director, Pfizer

·         Vincenzo Abbate,Research Associate, Kings College London

·         Dinesh V. Patel, President and CEO, Protagonist Therapeutics Inc.

·         Annette Friebe, Head, Late Discovery, Nexigen GmbH

·         Christophe Bonny, CSO, Bicycle Therapeutics

·         Doug Treco,President and CEO, Ra Pharmaceuitcals

Full event information can be found at http://www.smi-online.co.uk/pharmaceuticals/uk/conference... or early-bird places can be booked via Fateja Begum:  +44(0) 20 7827 6184.

Notes to editor

Sponsorship opportunities are available for this event, please contact Alia Malick on +44(0) 20 7827 6168.

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses  and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at www.smi-online.co.uk

Follow @SMIpharm today to get the latest pharma event updates on twitter